Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.

Details

Serval ID
serval:BIB_575D9D44300D
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.
Journal
Journal of Clinical Microbiology
Author(s)
Lamoth F., Damonti L., Alexander B.D.
ISSN
1098-660X (Electronic)
ISSN-L
0095-1137
Publication state
Published
Issued date
2016
Peer-reviewed
Oui
Volume
54
Number
6
Pages
1638-1640
Language
english
Abstract
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤0.5 μg/ml was significantly associated with better 6-week outcomes.
Pubmed
Web of science
Open Access
Yes
Create date
09/04/2016 16:33
Last modification date
20/08/2019 15:11
Usage data